FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

4074501000001101: Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072401000001114 Report only serious adverse reactions to the Committee on Safety of Medicines en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829401000001111 Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report only serious adverse reactions to the Committee on Safety of Medicines Is a CSM warning status messages true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Methylphenobarbitone 30mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prominal 200mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prominal 60mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prominal 30mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Clonazepam 2mg/5mL s/f oral solution - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Clonazepam 0.5mg/5mL s/f oral solution - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Rivotril 2mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Rivotril 500mcg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 100mg/5mL oral liquid - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 100mg chewable tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 200mg chewable tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 250mg suppository - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 125mg suppository - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Arbil MR 400mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Arbil MR 200mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol 200mg chewable tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol 100mg chewable tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol 400mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol 200mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Gabitril 15mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Gabitril 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Gabitril 5mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tiagabine 15mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tiagabine 10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tiagabine 5mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Topamax Sprinkle 50mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Topiramate 50mg beads in capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Topamax Sprinkle 25mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Topamax Sprinkle 15mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Topiramate 200mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Topiramate 100mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Topiramate 50mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Gabapentin 800mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol 100mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 400mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 200mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 100mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Pizotifen 250micrograms/5mL elixir - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Pizotifen 1.5mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Pizotifen 500micrograms tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sustac 2.6mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isoket 0.1% 10mg/10mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sorbid-40 SA m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Soni-Slo 40mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Soni-Slo 20mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isordil Tembids 40mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isoket Retard 20 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cedocard Retard 20mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sorbitrate 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mono-Cedocard 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Monit LS 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Monit 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ismo tablet starter pack CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ismo 20 tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Elantan 40mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Elantan 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Jeridin 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Monodur 60mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Monosorb XL 60 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isotard 60XL m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Modisal 60 XL m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ketanodur 60mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angeze SR 40 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Monomax SR 40 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angeze SR 60 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Monomax SR 60 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isosorbide mononitrate 40mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isosorbide mononitrate 60mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isib 60XL m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dynamin 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isosorbide mononitrate 50mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Elantan LA 50 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Imdur 60mg Durule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ismo 40 tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isosorbide mononitrate 50mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isosorbide mononitrate 25mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isotard 40XL m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Chemydur 60XL m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angiopine MR 20mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cardilate MR 20mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Coracten SR 10mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Adalat LA 60mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Adalat LA 30mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nifensar XL 20mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angiopine 10mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angiopine 5mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Coracten SR 20mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nivaten Retard 20mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Coracten XL 60mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Coracten XL 30mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nifedipine 60mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nifedipine 30mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nifedipress MR 20 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nivaten Retard 10mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nifedipress MR 10 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genalat Retard 20mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genalat Retard 10mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angiopine MR 10mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Slofedipine 20mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Adalat LA 20mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fortipine LA40 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier

Start Previous Page 75 of 118 Next End

This concept is not in any reference sets

Back to Start